No Photo Available

Last Update

2016-10-05T00:00:00.000Z

This profile was last updated on .

Is this you? Claim your profile.

Wrong Edward Sellers?

Dr. Edward M. Sellers

HQ Phone: (416) 648-2817

Get ZoomInfo Grow

+ Get 10 Free Contacts a Month

Please agree to the terms and conditions

I agree to the Terms of Service and Privacy Policy. I understand that I will receive a subscription to ZoomInfo Grow at no charge in exchange for downloading and installing the ZoomInfo Contact Contributor utility which, among other features, involves sharing my business contacts as well as headers and signature blocks from emails that I receive.

DL Global Partners Inc

Suite 100 78 Baby Point Cres.

Toronto, Ontario M6S 2C1

Canada

Company Description

DL Global Partners Inc. is an international consortium of consultants, key opinion leaders and services supporting drug and device development for disorders of the brain. We are the recognized scientific and opinion leaders in abuse potential assessment a ... more

Find other employees at this company (2)

Background Information

Employment History

Rx&D

Vice President, Early Stage

Kendle International Inc.

Affiliations

Founder
Nicogen Inc

Advisory Board Member
ElMindA Ltd

Founder
ValleVista Natural Health Inc.

Member
World Health Organization Expert Advisory Panel

Member of the Research Based Pharmaceutical Companies
Health Canada Committee

Professor Emeritus, Pharmacology, Medicine and Psychiatry
University of Toronto

President and Chief Executive Officer
DecisionLine Clinical Research Corporation

Scientific Advisory Board Member
WEX Pharmaceuticals Inc

Education

Faculty of Medicine

Harvard University

University of Toronto

H.L. Kaplan PhD

MD

MD

Harvard

Web References (90 Total References)


DL Global Partners Inc. - About Us

dlglobalpartners.com [cached]

Edward M. Sellers, MD, PhD, FRCPC, FACP President and Principal, DL Global Partners Inc.

An internationally recognized authority on clinical psychopharmacology, pharmacogenetics and smoking, abuse liability assessment and substance abuse. Dr. Sellers has been active in basic and applied science for over 40 years. During this time, he has published more than 350 peer reviewed papers and has been cited more than 26,000 times. He has a broad base of experience as an academic, hospital and CRO industry executive. During his career he has made not only pivotal scientific contributions but also, through his leadership and ability to problem solve, has been instrumental in successfully building programs, units and businesses. He is a founder of DecisionLine Clinical Research, Nicogen Inc. and ValleVista Natural Health Inc. As an independent consultant he has worked with academic institutions, hospitals, government agencies, investors and biopharmaceutical and device companies achieving a deep understanding of their needs. Areas of current focus include accelerating early stage drug development through new methods, optimizing strategies to assess abuse potential of new and re-formulated drugs and regulatory risk management and application of abuse liability methodology to modified risk tobacco related products.
After receiving his MD (Toronto 1965), PhD (Harvard 1971) and Internal Medicine specialty certification in both the United States and Canada (1972), Dr. Sellers began his scientific career at the University of Toronto in 1972 and rapidly rose to the rank of full Professor as he established the world's foremost clinical psychopharmacology unit which trained many of today's leaders in the field. During this period he also became responsible for the operations of the Clinical Institute of the Addiction Research Foundation, one of the world's largest and best known research and treatment organizations in the substance abuse field. With increasingly senior appointments at the University of Toronto, for a period of five years he was responsible for all of the academic programs at the Faculty of Medicine University of Toronto.
In 1997, he co-founded and served as President and CEO of DecisionLine Clinical Research Corporation which grew to be a world leading early stage CRO focused on CNS drug development with over 80 beds and 220 employees and 75 international clients until acquired in 2008 by Kendle International.
In 2010, he founded DL Global Partners Inc. He sits on numerous Scientific Advisory Boards of pharmaceutical and device companies and recently chaired the Scientific Advisory Panel on Opiate Analgesic Abuse for the Therapeutic Products Directorate, Health Canada.
Dr. Sellers has received numerous awards including the Rawls Palmer Progress in Medicine Award (1987 ASCPT); Nathan B. Eddy Award 2012 CPDD; Oscar B Hunter Award (2014 ASCPT).


DL Global Partners Inc. - Contact Us

dlglobalpartners.com [cached]

Edward M. Sellers President and Principal DL Global Partners Inc. e.sellers@dlglobalpartners.com


ElMindA - Visualizing your brain – revolutionizing treatment.

elminda.com [cached]

Edward Sellers, M.D., Ph.D

Founder and President of DL Global Partners, and Professor Emeritus of Pharmacology, Medicine and Psychiatry at University of Toronto, Canada


CIWA-Ar for Alcohol Withdrawal - MDCalc

www.mdcalc.com [cached]

Dr. Edward M. Sellers

Edward M. Sellers, MD, PhD, FRCPC, FACP, is the president and principal of DL Global Partners Inc., which specializes in clinical psychopharmacology and pharmacogenetics for substance abuse. He is also professor emeritus at the University of Toronto and helped establish its clinical psychopharmacology unit. Dr. Sellers has received several awards for his research in pharmacology and drug dependence, including the Rawls-Palmer Award given by the ASCPT.
To view Dr. Sellers' publications, visit PubMed
...
Dr. Edward M. Sellers
Edward M. Sellers, MD, PhD, FRCPC, FACP, is the president and principal of DL Global Partners Inc., which specializes in clinical psychopharmacology and pharmacogenetics for substance abuse. He is also professor emeritus at the University of Toronto and helped establish its clinical psychopharmacology unit. Dr. Sellers has received several awards for his research in pharmacology and drug dependence, including the Rawls-Palmer Award given by the ASCPT.
To view Dr. Sellers' publications, visit PubMed


DL Global Partners Inc. - About Us

www.dlglobalpartners.com [cached]

Edward M. Sellers, MD, PhD, FRCPC, FACP President and Principal, DL Global Partners Inc.

An internationally recognized authority on clinical psychopharmacology, pharmacogenetics and smoking, abuse liability assessment and substance abuse. Dr. Sellers has been active in basic and applied science for over 40 years. During this time, he has published more than 350 peer reviewed papers and has been cited more than 23,000 times. He has a broad base of experience as an academic, hospital and CRO industry executive. During his career he has made not only pivotal scientific contributions but also, through his leadership and ability to problem solve, has been instrumental in successfully building programs, units and businesses. He is a founder of DecisionLine Clinical Research, Nicogen Inc. and ValleVista Natural Health Inc. As an independent consultant he has worked with academic institutions, hospitals, government agencies, investors and biopharmaceutical and device companies achieving a deep understanding of their needs. Areas of current focus include accelerating early stage drug development through new methods, optimizing strategies to assess abuse potential of new and re-formulated drugs and regulatory risk management and application of abuse liability methodology to modified risk tobacco related products.
After receiving his MD (Toronto 1965), PhD (Harvard 1971) and Internal Medicine specialty certification (1972), Dr. Sellers began his scientific career at the University of Toronto in 1972 and rapidly rose to the rank of full Professor as he established the world's foremost clinical psychopharmacology unit which trained many of today's leaders in the field. During this period he also became responsible for the operations of the Clinical Institute of the Addiction Research Foundation, one of the world's largest and best known research and treatment organizations in the substance abuse field. With increasingly senior appointments at the University of Toronto, for a period of five years he was responsible for all of the academic programs at the Faculty of Medicine University of Toronto.
In 1997, he co-founded and served as President and CEO of DecisionLine Clinical Research Corporation which grew to be a world leading early stage CRO focused on CNS drug development with over 80 beds and 220 employees until acquired in 2008 by Kendle International.
In 2010, he founded DL Global Partners Inc. He sits on numerous Scientific Advisory Boards of pharmaceutical and device companies and recently chaired the Scientific Advisory Panel on Opiate Analgesic Abuse for the Therapeutic Products Directorate, Health Canada.
Dr. Sellers has received numerous awards including the Rawls Palmer Progress in Medicine Award (1987 ASCPT); Nathan B. Eddy Award 2012 CPDD; Oscar B Hunter Award (2014 ASCPT).

Similar Profiles

Other People with this Name

Other people with the name Sellers

Frederick Sellers
Baptist Health Care Inc

Jeff Sellers
Baffone & Matthews LLC

Michelle Sellers
Audi Bridgewater

Britney Sellers
SEAAHEC

Violet Sellers
BODYFIT PUNCH

City Directory Icon

Browse ZoomInfo's Business Contact Directory by City

People Directory Icon

Browse ZoomInfo's
Business People Directory

Company Directory Icon

Browse ZoomInfo's
Advanced Company Directory